Company: PTHS
Filing Date: 2025-05-27
Form Type: DEFM14C
Source: 0001140361-25-020509
Chunk: 573

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-27
Form: DEFM14C
Chunk 573
---
         -291 |     |         -1,506 |     |            — |
| Other assets and liabilities                                                                       |     |         -495 |     |            582 |     |          199 |
| Net cash used in operating activities                                                              |     |      -24,693 |     |         -4,022 |     |      -17,359 |
| Cash flow from investing activities:                                                               |     |              |     |                |     |              |
| Purchases of property and equipment                                                                |     |         -570 |     |              — |     |         -882 |
| Net cash used in investing activities                                                              |     |         -570 |     |              — |     |         -882 |
| Cash flow from financing activities:                                                               |     |              |     |                |     |              |
| Net transfer from parent                                                                           |     |       25,263 |     |          4,022 |     |       20,166 |
| Net cash provided by financing activities                                                          |     |       25,263 |     |          4,022 |     |       20,166 |
| Net increase in cash and cash equivalents                                                          |     |            — |     |              — |     |        1,925 |
| Cash and cash equivalents as of beginning of period                                                |     |            — |     |              — |     |        5,126 |
| Cash and cash equivalents as of end of period                                                      |     |           $— |     |             $— |     |       $7,051 |
| Supplemental disclosure of cash flow information:                                                  |     |              |     |                |     |              |
| Cash paid for interest                                                                             |     |           $— |     |             $— |     |           $— |
| Supplemental disclosure of non-cash investing and financing activities:                            |     |              |     |                |     |              |
| Purchases of property and equipment with accounts payable and accrued expenses as of end of period |     |         $162 |     |             $— |     |           $5 |

The accompanying notes are an integral part of these financial statements. F-75

#### TABLE OF CONTENTS

#### LNHC, Inc.

### Notes to Financial Statements
<div align='center'>**(dollar values in thousands, except for per share amounts)**</div>

### Note 1: Organization and Nature of Operations
LNHC, Inc. is a wholly-owned subsidiary of